BPTF and non-small cell lung carcinoma: We further find that the use of lumbrokinase down-regulates BPTF expression, alleviates the binding of BPTF at the specific promoter region of the VEGF gene, results in the decrease in VEGF expression, and finally synergizes with bevacizumab in NSCLC treatment.